Back to first-pass browser

First-pass extracted concept

ultrasound-responsive micro-/nanoplatforms

Candidate: concept label1 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This source describes ultrasound-responsive micro-/nanoplatforms as biomaterial-based systems that use ultrasound as a trigger for diagnostic imaging and therapy. The review frames them as platforms for disease-specific theranostic performance.

Source 1DOIPubMed

Resources required

The abstract indicates that these platforms require ultrasound plus responsive biomaterials produced or tuned through synthesis and material modification techniques. Biocompatibility, biosafety, and tissue-targeting features are presented as important design requirements.

Source 1DOIPubMed

What problem it solves

The platforms are presented as a way to achieve more precise diagnosis and treatment for specific diseases. The abstract also states that enhanced tissue targeting specificity can help minimize adverse drug reactions.

Source 1DOIPubMed

What it does not solve

The abstract does not claim that clinical translation problems are fully solved; instead it says challenges and solutions for translation are discussed. Specific unresolved technical limitations are not detailed in the abstract.

Source 1DOIPubMed

Alternatives

The abstract contrasts these platforms implicitly with ultrasound alone by emphasizing the added value of combining ultrasound with responsive biomaterials. No other specific alternative platform classes are named in the abstract.

Source 1DOIPubMed

Evidence Snippets

In this review, we introduce the biological effects of ultrasound and the classification of ultrasound-responsive micro-/nanoplatforms
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1application scopesupports2025Source 1DOIPubMed

Ultrasound-responsive micro-/nanoplatforms are described as having applications in diagnostic imaging and treatment across tumors, cardiovascular diseases, infectious diseases, neurological diseases, and metabolic diseases.

Quoted textsource-backed
we introduce the biological effects of ultrasound and the classification of ultrasound-responsive micro-/nanoplatforms, and systematically describe the relevant applications in the diagnostic imaging and treatment of tumors, cardiovascular diseases, infectious diseases, neurological diseases, and metabolic diseases.
Claim 2design principlesupports2025Source 1DOIPubMed

Combining ultrasound as a trigger with responsive biomaterials can establish platforms with diagnostic and therapeutic performance for specific diseases and is presented as a promising approach for precision medicine.

Quoted textsource-backed
By combining ultrasound as a trigger with responsive biomaterials, platforms with diagnostic and therapeutic performance for specific diseases could be established, offering a promising approach for the development of precise medicine.
Claim 3engineering propertysupports2025Source 1DOIPubMed

Synthesis and material modification techniques can endow diverse biomaterials with diagnostic or therapeutic properties while enhancing tissue targeting specificity and minimizing adverse drug reactions when biocompatibility and biosafety are maintained.

Quoted textsource-backed
Through various synthesis and material modification techniques, diverse biomaterials are endowed with diagnostic or therapeutic properties. While ensuring their biocompatibility and biosafety, their tissue targeting specificity is enhanced, thereby minimizing adverse drug reactions.
Claim 4general capabilitysupports2025Source 1DOIPubMed

Ultrasound is a widely used diagnostic and therapeutic modality in biomedicine because it is non-invasive, biocompatible, cost-effective, and has high tissue penetration depth.

Quoted textsource-backed
Ultrasound is a widely utilized diagnostic and therapeutic tool in biomedicine due to its non-invasiveness, biocompatibility, cost-effectiveness, and high tissue penetration depth.
Claim 5translational scopesupports2025Source 1DOIPubMed

The field includes relevant clinical trials and faces clinical translation challenges for which solutions have been proposed.

Quoted textsource-backed
Finally, we summarized relevant clinical trials in this field and proposed challenges and solutions in the process of clinical translation